Simon v. Roche Diagnostics Corporation ( 2021 )


Menu:
  • Case: 20-20661     Document: 00515925904         Page: 1     Date Filed: 07/06/2021
    United States Court of Appeals
    for the Fifth Circuit                         United States Court of Appeals
    Fifth Circuit
    FILED
    July 6, 2021
    No. 20-20661                     Lyle W. Cayce
    Summary Calendar                        Clerk
    Damon Simon; Patrice Simon,
    Plaintiffs—Appellants,
    versus
    Roche Diagnostics Corporation,
    Defendant—Appellee.
    Appeal from the United States District Court
    for the Southern District of Texas.
    USDC No. 4:20-CV-3625
    Before Higginbotham, Jones, and Costa, Circuit Judges.
    Per Curiam:*
    Damon Simon and his wife Patrice filed a personal injury suit in Texas
    state court against Roche Diagnostics Corporation (“Roche”) after
    Mr. Simon suffered a stroke.      Simon had been monitoring his blood’s
    anticoagulation levels using Roche’s “CoaguChek XS” at-home testing
    *
    Pursuant to 5th Circuit Rule 47.5, the court has determined that this
    opinion should not be published and is not precedent except under the limited
    circumstances set forth in 5th Circuit Rule 47.5.4.
    Case: 20-20661       Document: 00515925904           Page: 2   Date Filed: 07/06/2021
    No. 20-20661
    machine.      The couple allege the machine’s faulty test strips provided
    inaccurate results that left him unaware he was in danger of blood clots.
    Roche removed the case to the Southern District of Texas and moved to
    dismiss because plaintiffs’ claims were barred by Texas’s two-year statute of
    limitations. The district court granted the motion, and the Simons have
    appealed. We AFFIRM.
    In the early hours of May 26, 2018, Mr. Simon suffered a stroke,
    although plaintiffs assert that he had tested his anticoagulation level that
    evening with the Roche strips. The Simons allege that contrary to the strips’
    display, the hospital personnel informed them that Mr. Simon’s
    anticoagulation levels were very low, and that Mr. Simon’s anticoagulation
    levels “wouldn’t dip that fast.”
    In November of that year, Roche issued a nationwide recall of the
    CoaguChek strips that Mr. Simon had been using, and a Roche
    representative called Mr. Simon on November 2, 2018, asking him to return
    the strips.
    Close to two years later, the Texas Supreme Court extended most
    filing deadlines to September 15, 2020, because Texas was under a “state of
    emergency” due to the COVID-19 pandemic. The couple filed suit pro se
    against Roche on September 24, 2020.          As noted above, the case was
    dismissed for untimely filing under Texas law.
    DISCUSSION
    A district court’s grant of a motion to dismiss for failure to state a
    claim under Rule 12(b)(6) is subject to de novo review. Young v. Hosemann,
    
    598 F.3d 184
    , 188 (5th Cir. 2010).
    The Simons argue that their September 24, 2020, filing is not outside
    Texas’s two-year statute of limitations because the date their claims accrued
    2
    Case: 20-20661      Document: 00515925904           Page: 3      Date Filed: 07/06/2021
    No. 20-20661
    for statute of limitations purposes was the day that Roche telephoned
    Mr. Simon to recall the strips. Therefore, they continue, their September
    filing was timely, because the statutory period didn’t run until November 2,
    2020.    To support this alternative date, the Simons contend that the
    “discovery rule” applies to their case.
    In Texas, “a cause of action accrues and the two-year limitations
    period begins to run as soon as the owner suffers some injury, regardless of
    when the injury becomes discoverable.” Comput. Assocs. Int'l, Inc. v. Altai,
    Inc., 
    918 S.W.2d 453
    , 458 (Tex. 1996). The discovery rule is one of two
    exceptions that can extend the statute of limitations. BP Am. Prod. Co. v.
    Marshall, 
    342 S.W.3d 59
    , 65 (Tex. 2011). The discovery rule provides that
    “the cause of action does not accrue until the injury could reasonably have
    been discovered,” and it is applied “categorically to instances in which ‘the
    nature of the injury incurred is inherently undiscoverable and the evidence of
    injury is objectively verifiable.’” 
    Id.
     at 65–66 (citing Comput. Assocs. Int’l,
    Inc., 918 S.W.2d at 456). However, the discovery rule does not apply to cases
    where “the traumatic or injurious event causing personal injury is sudden
    and distinguishable, and the plaintiff knew that injury occurred at the time
    the event occurred.” Howard v. Fiesta Texas Show Park, Inc., 
    980 S.W.2d 716
    , 721 (Tex. App. 1998).
    Texas courts have applied the rule to certain types of latent injuries,
    like    mesothelioma    caused   by    exposure    to      asbestos   or   human
    immunodeficiency virus contracted by a nurse exposed to a patient’s blood.
    Childs v. Haussecker, 
    974 S.W.2d 31
    , 37–38 (Tex. 1998). Key in these cases is
    the latent nature of the injury, which typically means the injured party “does
    not and cannot immediately know about the injury or its cause because these
    injuries often do not manifest themselves for two or three decades following
    exposure to the hazardous substance.” Id. at 38. The discovery rule
    “operates to defer accrual of a cause of action until a plaintiff discovers or,
    3
    Case: 20-20661       Document: 00515925904          Page: 4    Date Filed: 07/06/2021
    No. 20-20661
    through the exercise of reasonable care and diligence, should discover the
    ‘nature of his injury.’” Id. at 40. Even in the category of latent-type injuries,
    such as those from exposure to asbestos, courts have determined that the
    statute of limitations begins to run when a plaintiff knows or should have
    known the cause of the injury. Glassock v. Armstrong Cork Co., 
    946 F.2d 1085
    ,
    1092 (5th Cir. 1991).
    In this case, the injury was immediately apparent—Mr. Simons
    suffered a stroke. Further, given the proximity between the stroke and the
    perhaps erroneous reading on the Roche device, compounded by the hospital
    personnel’s statement that the levels don’t dip that fast, their pleadings
    indicate that they should have known his stroke was likely caused by the faulty
    product. Consequently, even under the discovery rule, the date of the
    injury—May 26, 2018—was the date the statute of limitations began to run.
    We see nothing in Texas law that suggests this fact-specific
    application of the discovery rule merits certification to the state Supreme
    Court.
    The district court correctly held that the Simons’s claim is time-
    barred by the Texas statute of limitations.                       AFFIRMED.
    4